A randomized, multicenter, double-blind, placebo-controlled trial to demonstrate the safety and efficacy of daily 0.3 mg synthetic conjugated estrogens, A (Cenestin) for the treatment of vasomotor symptoms in postmenopausal women

Trial Profile

A randomized, multicenter, double-blind, placebo-controlled trial to demonstrate the safety and efficacy of daily 0.3 mg synthetic conjugated estrogens, A (Cenestin) for the treatment of vasomotor symptoms in postmenopausal women

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Jul 2009

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Hot flashes; Menopause
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Mar 2008 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
    • 10 Mar 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top